I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Pembrolizumab as Second-Line Therapy for Advanced Hepatocel..:
Merle, Philippe
;
Kudo, Masatoshi
;
Edeline, Julien
...
info:eu-repo/semantics/altIdentifier/doi/10.1159/000529636. , 2023
Link:
https://hal.science/hal-04265920
RT Journal T1
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial
UL https://suche.suub.uni-bremen.de/peid=base-ftunivlyon:oai:HAL:hal-04265920v1&Exemplar=1&LAN=DE A1 Merle, Philippe A1 Kudo, Masatoshi A1 Edeline, Julien A1 Bouattour, Mohamed A1 Cheng, Ann-Lii A1 Chan, Stephen A1 Yau, Thomas A1 Garrido, Marcelo A1 Knox, Jennifer A1 Daniele, Bruno A1 Breder, Valeriy A1 Lim, Ho Yeong A1 Ogasawara, Sadahisa A1 Cattan, Stéphane A1 Chao, Yee A1 B. Siegel, Abby A1 Martinez-Forero, Iván A1 Wei, Ziwen A1 Liu, C A1 Finn, Richard PB HAL CCSD; S. Karger YR 2023 K1 Pembrolizumab K1 Medicine K1 Placebo K1 Sorafenib K1 Internal medicine K1 Clinical endpoint K1 Randomization K1 Gastroenterology K1 Hepatocellular carcinoma K1 Randomized controlled trial K1 Oncology K1 Cancer K1 Immunotherapy K1 Pathology K1 Alternative medicine K1 [SDV.CAN]Life Sciences [q-bio]/Cancer JF info:eu-repo/semantics/altIdentifier/doi/10.1159/000529636 LK http://dx.doi.org/https://hal.science/hal-04265920 DO https://hal.science/hal-04265920 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)